Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Eclinicalmedicine|September 6, 2021
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19Raymund R Razonable, Colin Pawlowski, John C O'Horo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Multiple Allosteric Sites Allow for Synergistic Enhancement of GPCR SignalingKai Wang, Snezana T Dimova, John N Hanson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 2, 2021
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19Ravindra Ganesh, Colin Pawlowski, John C O'Horo, et al.
The Journal of Infectious Diseases|July 19, 2021
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, et al.
The Journal of Clinical Investigation|August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.
Plos One|October 7, 2020
The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studiesFallon K Noto, Jaya Sangodkar, Bisoye Towobola Adedeji, et al.
ACS Pharmacology & Translational Science|February 19, 2026
Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand PharmacokineticsMohammad Alkhatib, Franziska M Jakobs, John N Hanson, et al.
Mbio|April 11, 2024
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19Juan G Ripoll, Sidna M Tulledge-Scheitel, Anthony A Stephenson, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 16, 2023
Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening ScorePatrick W Johnson, Katie L Kunze, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|May 7, 2021
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic ModelRaymund R Razonable, Nicole C E Aloia, Ryan J Anderson, et al.
Pageof 19